Journal of Biological Chemistry· 2026Q1
İki hücre bağlamında süksinat dehidrojenaz kaybına farklı proteomik ve açilproteomik adaptasyonlar
Distinct proteomic and acylproteomic adaptations to succinate dehydrogenase loss in two cell contexts
- 1atıf
- Q1SCImago
- 2026yıl
Kısa özet
Süksinat dehidrojenaz (SDH) kaybı, fare kromafin hücrelerinde (imCC'ler) benzersiz şekilde mitokondriyal proteinleri ve yağ asidi oksidasyonunu (FAO) artırırken, fibroblastlarda (iMEF'ler) artırmaz, bu da hücre tipine özgü metabolik adaptasyonları ortaya koyar.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Ana noktalar
- SDH kaybı olan imCC'ler, iMEF'lerin aksine, önemli ölçüde mitokondriyal proteinlerin yukarı regülasyonunu ve nükleer proteinlerin aşağı regülasyonunu gösterir.
- Yağ asidi β-oksidasyon (FAO) aktivitesi, iMEF'lerde değil, SDH kaybı olan imCC'lerde benzersiz şekilde artar.
- SDH kaybı her iki hücre tipinde de orantısız hiperasetilasyona neden olur, ancak imCC'ler benzersiz bir şekilde mitokondriyal proteinlerin hipoasetilasyonunu gösterir.
- SDH kaybı karışık süksinilasyon modellerine yol açar, imCC'ler mitokondriyal proteinlerin hiposüksinilasyonunu gösterir.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
Background: The tricarboxylic acid (TCA) cycle and electron transport chain (ETC) are key metabolic pathways required for cellular ATP production. While loss of components in these pathways typically impairs cell survival, such defects can paradoxically promote tumorigenesis in certain cell types. One such example is loss of succinate dehydrogenase (SDH), which functions in both the TCA cycle and as Complex II of the ETC. Deleterious mutations in SDH subunits can cause pheochromocytoma and paraganglioma (PPGL), rare hereditary neuroendocrine tumors of chromaffin cells in the adrenal gland and the nerve ganglia, respectively. Why tumor formation upon SDH loss is limited to certain tissues remains unclear. We hypothesized that the metabolic and proteomic perturbations resulting from SDH loss are cell-type specific, favoring survival of chromaffin cells. Methods: We comprehensively examined the proteomic, acetylproteomic, and succinylproteomic effects of SDH loss in two cell models, immortalized mouse chromaffin cells (imCCs) and immortalized mouse embryonic fibroblasts (iMEFs). Perturbations in metabolite levels were determined by mass spectrometry. Effects of SDH loss on fatty acid β-oxidation (FAO) were assessed by stable isotope tracing and pharmacologic inhibition. Results: SDH-loss imCCs show significant upregulation of mitochondrial proteins, including TCA cycle and FAO enzymes, with pronounced downregulation of nuclear proteins. Both imCCs and iMEFs demonstrate significant energy deficiency upon SDH loss, but FAO activity is uniquely increased in SDH-loss imCCs. While SDH loss increases both lysine-reactive acetyl-CoA and succinyl-CoA, SDH-loss imCCs and iMEFs show disproportionate hyperacetylation but mixed succinylation. Surprisingly, SDH-loss imCCs, but not iMEFs, display disproportionate hypoacetylation and hyposuccinylation of mitochondrial proteins. Conclusions: SDH loss differentially impacts the proteomes and acylproteomes of imCCs and iMEFs, with compartment-specific effects. These findings reveal cell type-specific adaptations to SDH loss. The plasticity of the response of imCCs may underlie the tissue-specific susceptibility to tumorigenesis and could illuminate therapeutic vulnerabilities of SDH-loss tumors.
Yazarların özeti; kaynağından alınmıştır. Journal of Biological Chemistry, 2026 · DOI ↗
Ücretsiz hesapla devam et
Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.
Web'de ücretsiz devam etGoogle ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.
Telefonda:
Cancer ResearchBiochemistry, Genetics and Molecular Biology